Table 1.
compounds | R1 | R2 | CIG5 (%) | IL-6 (%) |
---|---|---|---|---|
7 | 5-OMe, 7-OMe | H | 86 ± 11 | 75 ± 8.6 |
10 | H | H | −26 ± 3.1 | 81 ± 8.9 |
11 | 5-F | H | 33 ± 4.8 | 62 ± 7.2 |
12 | 6-F | H | −4.5 ± 0.6 | 62 ± 7.1 |
13 | 6-Cl | H | 37 ± 4.9 | 53 ± 5.6 |
14 | 6-Br | H | 43 ± 6.1 | 25 ± 3.4 |
15 | 7-Br | H | 51 ± 6.3 | 15 ± 1.9 |
16 | 7-(1-methyl-1H-pyrazol-3-yl) | H | 71 ± 8.5 | −24 ± 2.8 |
19 | 7-NO2 | CH3 | −69 ± 7.4 | 86 ± 9.1 |
22 | H | CH3 | 18 ± 2.3 | 55 ± 6.5 |
Inhibitory rates (%) are reported as mean ± SD of expression in the compound divided by that in solvent (×100). Data are derived from three independent measurements (n = 3).